Orthogen International GmbH v. Douglas Schottenstein

For use in a civil proceeding that Orthogen plans to file in Germany based on the underpayment of royalties, it was due from two of its licensees, Mr. Edward Capla and Dr. Douglas Schottenstein, Orthogen International GmbH (a “German biotech company that licenses its propriety medical treatments to physicians around the world”), has filed an application with the United States District Court for the Southern District of New York to take discovery from those parties.